CD8+ T lymphocyte toxicity is also an important component of vitiligo pathogenesis, therefore therapies blocking IFN-γ, the IFN-γ receptor, the ligands CXCL10 and CXCL9 and the receptor CXCR3 may also be worth exploring and testing in clinical studies [70]. The gene discussed is CXCR3; the disease is vitiligo.